CTIS2022-501649-54-01进行中（未招募）1 期
Dapiglutide for the treatment of obesity (DREAM): a randomised, double-blind, placebo-controlled, investigator-initiated trial - The ‘DREAM’ trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •Age 18–75 years, BMI = 30 kg/m², History of at least one attempt to lose body weight
排除标准
- •A self-reported change in body weight = 5% within the last 90 days prior to the screening visit, Treatment with any therapy, including endoscopic procedures and/or medication (e.g. liraglutide, bupropion/naltrexone and orlistat), intended for weight management within 90 days prior to screening, Previous, current, or planned (during the trial period) obesity treatment with surgery or a weight loss device < 1 year prior to screening, Glycated haemoglobin (HbA1c) = 48 mmol/mol, History of type 1 diabetes or type 2 diabetes
研究者
相似试验
进行中（未招募）
2 期
Dapiglutide for the Treatment of ObesityInflammationObesityNCT05788601University Hospital, Gentofte, Copenhagen54
尚未招募
不适用
A pilot study to investigate the use of dexamphetamine to treat obesity complicated by diabetes or obstructive sleep apnoeaObstructive sleep apnoeaType 2 diabetesDiet and Nutrition - ObesityRespiratory - Sleep apnoeaMetabolic and Endocrine - DiabetesObesityACTRN12613000727741epean Hospital24
暂停
2 期
The research for the efficacy of adipose derived stem cell therapy for liver cirrhosisiver cirrhosisJPRN-jRCTb070200009Itano Satoshi6
招募中
不适用
A clinical trial evaluating anti-obesity and antilipidemic effects of Schizandra chinensisEndocrine, nutritional and metabolic diseaseKCT0000649Dongguk University Ilsan Oriental Hospital30
进行中（未招募）
1 期
iraglutide to overweight patients with insulin treated type 2 diabetesEUCTR2012-001941-42-SEVästra Götalandsregionen (VGR)120